1. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
   HO-JIN PARK et al, 2013, International Journal of Oncology CrossRef
2. Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy
   Marieke A de Graaff et al, 2016, British Journal of Cancer CrossRef
3. BNIP3 Regulates AT101 [(-)-Gossypol] Induced Death in Malignant Peripheral Nerve Sheath Tumor Cells
   Niroop Kaza et al, 2014, PLoS ONE CrossRef
4. Programmed cell death, redox imbalance, and cancer therapeutics
   Xiaofeng Dai et al, 2021, Apoptosis CrossRef
5. The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL
   QI SUN et al, 2015, International Journal of Oncology CrossRef
6. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors
   Jacqueline D Peacock et al, 2013, Journal of Translational Medicine CrossRef
7. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor
   Gun-Hoo Park et al, 2021, International Journal of Molecular Sciences CrossRef
8. Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
   Jolieke G. van Oosterwijk et al, 2013, The American Journal of Pathology CrossRef
9. Survivin and YM155: How faithful is the liaison?
   Anke Rauch et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions
    GUN-HOO PARK et al, 2014, Oncology Reports CrossRef